SAN FRANCISCO, August 14, 2018 /PRNewswire/ --
The global diabetes devices market size is expected to reach USD 35.5 billion by 2024, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 7.0% during the forecast period. Growing cases of diabetes, due to obesity, sedentary and unhealthy lifestyles, and several other factors, is expected to drive demand for diabetes devices over the next few years.
(Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )
Obesity is believed to be one of the foremost factors leading to diabetes in individuals. According to WHO, in 2014, over 1.9 billion people were identified to be overweight, of which, around 600 million people were obese.
Some of the key companies in the global diabetes devices market are Medtronic PLC, Sanofi S.A., Bayer Healthcare AG, Becton, Dickinson and Company, Novo Nordisk A/S, Abbott Laboratories, F. Hoffman-La Roche AG, and Johnson & Johnson.
Browse full research report with TOC on "Diabetes Devices Market Analysis By Device Type (Self-monitoring & Diagnostic Devices (Lancets, Analog Glucose Meter, Continuous Glucose Monitor & Test Strips)), Delivery Type (Syringes, Pumps, Pens, Injectors) And Segment Forecasts To 2024" at: https://www.grandviewresearch.com/industry-analysis/diabetes-devices-market
Further Key Findings From the Report Suggest:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected]
Web: https://www.grandviewresearch.com
SOURCE Grand View Research, Inc.
Advertisement
The global diabetes devices market size is expected to reach USD 35.5 billion by 2024, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 7.0% during the forecast period. Growing cases of diabetes, due to obesity, sedentary and unhealthy lifestyles, and several other factors, is expected to drive demand for diabetes devices over the next few years.
Advertisement
(Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )
Obesity is believed to be one of the foremost factors leading to diabetes in individuals. According to WHO, in 2014, over 1.9 billion people were identified to be overweight, of which, around 600 million people were obese.
Some of the key companies in the global diabetes devices market are Medtronic PLC, Sanofi S.A., Bayer Healthcare AG, Becton, Dickinson and Company, Novo Nordisk A/S, Abbott Laboratories, F. Hoffman-La Roche AG, and Johnson & Johnson.
Browse full research report with TOC on "Diabetes Devices Market Analysis By Device Type (Self-monitoring & Diagnostic Devices (Lancets, Analog Glucose Meter, Continuous Glucose Monitor & Test Strips)), Delivery Type (Syringes, Pumps, Pens, Injectors) And Segment Forecasts To 2024" at: https://www.grandviewresearch.com/industry-analysis/diabetes-devices-market
Further Key Findings From the Report Suggest:
- Constantly rising target population base is the primary factor driving market growth
- Test strips captured the largest share in the monitoring and diagnostics device segment while insulin pens accounted for the largest revenue share among insulin delivery devices in 2016. This can be attributed to rapid adoption of these user-friendly, quick, and accurate devices for homecare use
- North America is leading the regional market, followed by Europe. Advanced healthcare infrastructure and availability of technologically advanced products have driven the regional market
- Key players in the market include Medtronic PLC, Sanofi S.A., Bayer Healthcare AG, Becton Dickinson and Company, Novo Nordisk A/S, Abbott Laboratories, F. Hoffman-La Roche AG and Johnson & Johnson.
- Immunohematology Market - The global immunohematology market size was valued at USD 1.5 billion in 2015.
- Disposable Syringes Market - The global disposable syringes market size was valued at USD 6.4 billion in 2015. The market is expected to grow due to growing demand for injectable drugs.
- Dental X-Ray Market - The global dental x-ray market was estimated to be USD 1.2 billion in 2015 and is expected to grow at a CAGR of 8.5% during the forecast period.
- Osteosynthesis Devices Market - The global osteosynthesis devices market size was valued at USD 5.5 billion in 2015.
- Diabetes Devices Product Type Outlook (Revenue, USD Million, 2014 - 2024)
- Monitoring and Diagnostic Devices
- Lancets
- Analog Glucose Monitor
- Continuous Glucose Monitor
- Test Strips
- Insulin Delivery Devices
- Syringe
- Pens
- Pumps
- Injectors
- Monitoring and Diagnostic Devices
- Diabetes Devices Regional Outlook (Revenue, USD Million, 2014 - 2024)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- China
- India
- Latin America
- Mexico
- Brazil
- MEA
- UAE
- North America
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected]
Web: https://www.grandviewresearch.com
SOURCE Grand View Research, Inc.
